Bryan T. Harada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bryan T. Harada has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Chuan He
Department of Chemistry, University of Chicago, Chicago, USA
11 shared publications - Jiangbo Wei
Department of Chemistry, The University of Chicago, Chicago, USA
4 shared publications - Qing Dai
Department of Chemistry, The University of Chicago, Chicago, USA
4 shared publications - Xiaowei Zhuang
Howard Hughes Medical Institute, Chevy Chase, MD, USA
4 shared publications Yuru Wang
Department of Chemistry, The University of Chicago, Chicago, USA
4 shared publications- Mengjie Chen
University of Chicago
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 17 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 379 (6633) , 677-682
Exon architecture controls mRNA m 6 A suppression and gene expression
N 6 -methyladenosine (m 6 A) is the most abundant messenger RNA (mRNA) modification and plays crucial roles in diverse physiological processes. Using a massively parallel assay for m 6 A (MPm 6 A), we discover that m 6 A specificity is globally regulated by suppressors that prevent m 6 A deposition in unmethylated transcriptome regions. We identify exon junction complexes (EJCs) as m 6 A suppressors that protect exon junction–proximal RNA within coding sequences from methylation and regulate mRNA stability through m 6 A suppression. EJC suppression of m 6 A underlies multiple global characteristics of mRNA m 6 A specificity, with the local range of EJC protection sufficient to suppress m 6 A deposition in average-length internal exons but not in long internal and terminal exons. EJC-suppressed methylation sites colocalize with EJC-suppressed splice sites, which suggests that exon architecture broadly determines local mRNA accessibility to regulatory complexes.
- 17 February 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 379 (6633) , 677-682
Top Cited PapersOpen AccessExon architecture controls mRNA m 6 A suppression and gene expression
N 6 -methyladenosine (m 6 A) is the most abundant messenger RNA (mRNA) modification and plays crucial roles in diverse physiological processes. Using a massively parallel assay for m 6 A (MPm 6 A), we discover that m 6 A specificity is globally regulated by suppressors that prevent m 6 A deposition in unmethylated transcriptome regions. We identify exon junction complexes (EJCs) as m 6 A suppressors that protect exon junction–proximal RNA within coding sequences from methylation and regulate mRNA stability through m 6 A suppression. EJC suppression of m 6 A underlies multiple global characteristics of mRNA m 6 A specificity, with the local range of EJC protection sufficient to suppress m 6 A deposition in average-length internal exons but not in long internal and terminal exons. EJC-suppressed methylation sites colocalize with EJC-suppressed splice sites, which suggests that exon architecture broadly determines local mRNA accessibility to regulatory complexes.
- Open Access
- 30 November 2022
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (1) , 150
Author Correction: m6A RNA modifications are measured at single-base resolution across the mammalian transcriptome
- 30 November 2022
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (1) , 150
Open AccessAuthor Correction: m6A RNA modifications are measured at single-base resolution across the mammalian transcriptome
- Top Cited PapersOpen Access
- 27 October 2022
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (3) , 344-354
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
Functional characterization of pseudouridine (Ψ) in mammalian mRNA has been hampered by the lack of a quantitative method that maps Ψ in the whole transcriptome. We report bisulfite-induced deletion sequencing (BID-seq), which uses a bisulfite-mediated reaction to convert pseudouridine stoichiometrically into deletion upon reverse transcription without cytosine deamination. BID-seq enables detection of abundant Ψ sites with stoichiometry information in several human cell lines and 12 different mouse tissues using 10–20 ng input RNA. We uncover consensus sequences for Ψ in mammalian mRNA and assign different ‘writer’ proteins to individual Ψ deposition. Our results reveal a transcript stabilization role of Ψ sites installed by TRUB1 in human cancer cells. We also detect the presence of Ψ within stop codons of mammalian mRNA and confirm the role of Ψ in promoting stop codon readthrough in vivo. BID-seq will enable future investigations of the roles of Ψ in diverse biological processes.
- 27 October 2022
- Published by Springer Nature in Nature Biotechnology
- Vol. 41 (3) , 344-354
Top Cited PapersOpen AccessQuantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
Functional characterization of pseudouridine (Ψ) in mammalian mRNA has been hampered by the lack of a quantitative method that maps Ψ in the whole transcriptome. We report bisulfite-induced deletion sequencing (BID-seq), which uses a bisulfite-mediated reaction to convert pseudouridine stoichiometrically into deletion upon reverse transcription without cytosine deamination. BID-seq enables detection of abundant Ψ sites with stoichiometry information in several human cell lines and 12 different mouse tissues using 10–20 ng input RNA. We uncover consensus sequences for Ψ in mammalian mRNA and assign different ‘writer’ proteins to individual Ψ deposition. Our results reveal a transcript stabilization role of Ψ sites installed by TRUB1 in human cancer cells. We also detect the presence of Ψ within stop codons of mammalian mRNA and confirm the role of Ψ in promoting stop codon readthrough in vivo. BID-seq will enable future investigations of the roles of Ψ in diverse biological processes.
- Top Cited Papers
- 14 March 2022
- Published by Springer Nature in Nature Biotechnology
- Vol. 40 (8) , 1210-1219
m6A RNA modifications are measured at single-base resolution across the mammalian transcriptome
Functional studies of the RNA N6-methyladenosine (m6A) modification have been limited by an inability to map individual m6A-modified sites in whole transcriptomes. To enable such studies, here, we introduce m6A-selective allyl chemical labeling and sequencing (m6A-SAC-seq), a method for quantitative, whole-transcriptome mapping of m6A at single-nucleotide resolution. The method requires only ~30 ng of poly(A) or rRNA-depleted RNA. We mapped m6A modification stoichiometries in RNA from cell lines and during in vitro monocytopoiesis from human hematopoietic stem and progenitor cells (HSPCs). We identified numerous cell-state-specific m6A sites whose methylation status was highly dynamic during cell differentiation. We observed changes of m6A stoichiometry as well as expression levels of transcripts encoding or regulated by key transcriptional factors (TFs) critical for HSPC differentiation. m6A-SAC-seq is a quantitative method to dissect the dynamics and functional roles of m6A sites in diverse biological processes using limited input RNA.
- 14 March 2022
- Published by Springer Nature in Nature Biotechnology
- Vol. 40 (8) , 1210-1219
Top Cited Papersm6A RNA modifications are measured at single-base resolution across the mammalian transcriptome
Functional studies of the RNA N6-methyladenosine (m6A) modification have been limited by an inability to map individual m6A-modified sites in whole transcriptomes. To enable such studies, here, we introduce m6A-selective allyl chemical labeling and sequencing (m6A-SAC-seq), a method for quantitative, whole-transcriptome mapping of m6A at single-nucleotide resolution. The method requires only ~30 ng of poly(A) or rRNA-depleted RNA. We mapped m6A modification stoichiometries in RNA from cell lines and during in vitro monocytopoiesis from human hematopoietic stem and progenitor cells (HSPCs). We identified numerous cell-state-specific m6A sites whose methylation status was highly dynamic during cell differentiation. We observed changes of m6A stoichiometry as well as expression levels of transcripts encoding or regulated by key transcriptional factors (TFs) critical for HSPC differentiation. m6A-SAC-seq is a quantitative method to dissect the dynamics and functional roles of m6A sites in diverse biological processes using limited input RNA.
- 29 November 2021
- Published by Elsevier in Molecular Cell
- Vol. 81 (24) , 5052-5065.e6
HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease
- 29 November 2021
- Published by Elsevier in Molecular Cell
- Vol. 81 (24) , 5052-5065.e6
HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease
- 12 July 2021
- Published by Springer Nature in Nature Cell Biology
- Vol. 23 (7) , 684-691
ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing
Members of the mammalian AlkB family are known to mediate nucleic acid demethylation1,2. ALKBH7, a mammalian AlkB homologue, localizes in mitochondria and affects metabolism3, but its function and mechanism of action are unknown. Here we report an approach to site-specifically detect N1-methyladenosine (m1A), N3-methylcytidine (m3C), N1-methylguanosine (m1G) and N2,N2-dimethylguanosine (m22G) modifications simultaneously within all cellular RNAs, and discovered that human ALKBH7 demethylates m22G and m1A within mitochondrial Ile and Leu1 pre-tRNA regions, respectively, in nascent polycistronic mitochondrial RNA4,5,6. We further show that ALKBH7 regulates the processing and structural dynamics of polycistronic mitochondrial RNAs. Depletion of ALKBH7 leads to increased polycistronic mitochondrial RNA processing, reduced steady-state mitochondria-encoded tRNA levels and protein translation, and notably decreased mitochondrial activity. Thus, we identify ALKBH7 as an RNA demethylase that controls nascent mitochondrial RNA processing and mitochondrial activity.
- 12 July 2021
- Published by Springer Nature in Nature Cell Biology
- Vol. 23 (7) , 684-691
ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing
Members of the mammalian AlkB family are known to mediate nucleic acid demethylation1,2. ALKBH7, a mammalian AlkB homologue, localizes in mitochondria and affects metabolism3, but its function and mechanism of action are unknown. Here we report an approach to site-specifically detect N1-methyladenosine (m1A), N3-methylcytidine (m3C), N1-methylguanosine (m1G) and N2,N2-dimethylguanosine (m22G) modifications simultaneously within all cellular RNAs, and discovered that human ALKBH7 demethylates m22G and m1A within mitochondrial Ile and Leu1 pre-tRNA regions, respectively, in nascent polycistronic mitochondrial RNA4,5,6. We further show that ALKBH7 regulates the processing and structural dynamics of polycistronic mitochondrial RNAs. Depletion of ALKBH7 leads to increased polycistronic mitochondrial RNA processing, reduced steady-state mitochondria-encoded tRNA levels and protein translation, and notably decreased mitochondrial activity. Thus, we identify ALKBH7 as an RNA demethylase that controls nascent mitochondrial RNA processing and mitochondrial activity.
- 17 March 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (8) , e106276
N6‐methyladenosine modification of lncRNA Pvt1 governs epidermal stemness
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 17 March 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (8) , e106276
N6‐methyladenosine modification of lncRNA Pvt1 governs epidermal stemness
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 18 January 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (5) , e106309
m6A deposition is regulated by PRMT1‐mediated arginine methylation of METTL14 in its disordered C‐terminal region
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 18 January 2021
- Published by Springer Nature in The EMBO Journal
- Vol. 40 (5) , e106309
m6A deposition is regulated by PRMT1‐mediated arginine methylation of METTL14 in its disordered C‐terminal region
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 24 August 2020
- Published by Springer Nature in Nature Biotechnology
- Vol. 39 (2) , 225-235
Direct DNA crosslinking with CAP-C uncovers transcription-dependent chromatin organization at high resolution
Determining the spatial organization of chromatin in cells mainly relies on crosslinking-based chromosome conformation capture techniques, but resolution and signal-to-noise ratio of these approaches is limited by interference from DNA-bound proteins. Here we introduce chemical-crosslinking assisted proximity capture (CAP-C), a method that uses multifunctional chemical crosslinkers with defined sizes to capture chromatin contacts. CAP-C generates chromatin contact maps at subkilobase (sub-kb) resolution with low background noise. We applied CAP-C to formaldehyde prefixed mouse embryonic stem cells (mESCs) and investigated loop domains (median size of 200 kb) and nonloop domains (median size of 9 kb). Transcription inhibition caused a greater loss of contacts in nonloop domains than loop domains. We uncovered conserved, transcription-state-dependent chromatin compartmentalization at high resolution that is shared from Drosophila to human, and a transcription-initiation-dependent nuclear subcompartment that brings multiple nonloop domains in close proximity. We also showed that CAP-C could be used to detect native chromatin conformation without formaldehyde prefixing.
- 24 August 2020
- Published by Springer Nature in Nature Biotechnology
- Vol. 39 (2) , 225-235
Direct DNA crosslinking with CAP-C uncovers transcription-dependent chromatin organization at high resolution
Determining the spatial organization of chromatin in cells mainly relies on crosslinking-based chromosome conformation capture techniques, but resolution and signal-to-noise ratio of these approaches is limited by interference from DNA-bound proteins. Here we introduce chemical-crosslinking assisted proximity capture (CAP-C), a method that uses multifunctional chemical crosslinkers with defined sizes to capture chromatin contacts. CAP-C generates chromatin contact maps at subkilobase (sub-kb) resolution with low background noise. We applied CAP-C to formaldehyde prefixed mouse embryonic stem cells (mESCs) and investigated loop domains (median size of 200 kb) and nonloop domains (median size of 9 kb). Transcription inhibition caused a greater loss of contacts in nonloop domains than loop domains. We uncovered conserved, transcription-state-dependent chromatin compartmentalization at high resolution that is shared from Drosophila to human, and a transcription-initiation-dependent nuclear subcompartment that brings multiple nonloop domains in close proximity. We also showed that CAP-C could be used to detect native chromatin conformation without formaldehyde prefixing.
- 1 June 2019
- Published by Elsevier in Trends in Cell Biology
- Vol. 29 (6) , 487-499
Regulation of Gene Expression by N-methyladenosine in Cancer
- 1 June 2019
- Published by Elsevier in Trends in Cell Biology
- Vol. 29 (6) , 487-499
Regulation of Gene Expression by N-methyladenosine in Cancer